2020 Q4 Form 10-K Financial Statement

#000143774921003789 Filed on February 23, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $713.4M $702.7M $678.8M
YoY Change 5.41% 7.66% 4.01%
Cost Of Revenue $260.5M $240.0M $235.8M
YoY Change 0.27% -1.19% -2.84%
Gross Profit $452.9M $462.7M $443.0M
YoY Change 8.61% 12.91% 8.08%
Gross Profit Margin 63.48% 65.85% 65.26%
Selling, General & Admin $109.1M $96.40M $96.40M
YoY Change -16.46% -62.2% -14.16%
% of Gross Profit 24.09% 20.83% 21.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $93.20M $49.40M $45.90M
YoY Change 8.88% 7.86% 0.44%
% of Gross Profit 20.58% 10.68% 10.36%
Operating Expenses $202.3M $96.40M $96.40M
YoY Change -9.04% -62.2% -14.16%
Operating Profit $250.6M $275.4M $259.7M
YoY Change 28.78% 296.26% 18.96%
Interest Expense -$34.60M $35.30M $34.20M
YoY Change 22.26% 12.78% 12.13%
% of Operating Profit -13.81% 12.82% 13.17%
Other Income/Expense, Net -$35.40M -$34.90M
YoY Change 15.69% 12.58%
Pretax Income $216.0M $240.0M $224.8M
YoY Change 25.51% 516.97% 20.02%
Income Tax $39.80M $54.20M $45.80M
% Of Pretax Income 18.43% 22.58% 20.37%
Net Earnings $176.2M $185.8M $179.0M
YoY Change 33.28% 464.74% 19.02%
Net Earnings / Revenue 24.7% 26.44% 26.37%
Basic Earnings Per Share $1.14 $1.10
Diluted Earnings Per Share $1.070M $1.12 $1.08
COMMON SHARES
Basic Shares Outstanding 162.6M 162.5M 162.4M
Diluted Shares Outstanding 165.7M 165.1M

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $218.8M $221.8M $309.4M
YoY Change 18.53% -28.86% 101.83%
Cash & Equivalents $218.8M $221.8M $309.4M
Short-Term Investments
Other Short-Term Assets $36.40M $36.20M $33.20M
YoY Change 104.49% 95.68% 24.81%
Inventory
Prepaid Expenses $81.20M $82.30M $81.60M
Receivables $432.4M $433.4M $454.5M
Other Receivables $25.40M $26.00M $0.00
Total Short-Term Assets $794.2M $799.7M $878.7M
YoY Change 6.62% -3.77% 23.71%
LONG-TERM ASSETS
Property, Plant & Equipment $632.3M $606.4M $560.1M
YoY Change 15.36% 3.39% -1.13%
Goodwill $4.108B $3.925B $3.744B
YoY Change 6.31% 16.57% 10.1%
Intangibles $1.385B $1.316B $1.264B
YoY Change -1.01% 15.34% 5.9%
Long-Term Investments
YoY Change
Other Assets $365.7M $325.0M $309.3M
YoY Change 128.85% 148.85% 155.83%
Total Long-Term Assets $6.768B $6.420B $6.129B
YoY Change 7.25% 17.62% 10.96%
TOTAL ASSETS
Total Short-Term Assets $794.2M $799.7M $878.7M
Total Long-Term Assets $6.768B $6.420B $6.129B
Total Assets $7.562B $7.220B $7.008B
YoY Change 7.18% 14.8% 12.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $406.7M $369.3M $322.4M
YoY Change 8.45% 1.79% 36.21%
Accrued Expenses $38.70M $39.20M $37.90M
YoY Change -4.68% -0.51% -1.04%
Deferred Revenue $466.7M
YoY Change 6.04%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $514.3M $460.4M $453.0M
YoY Change 2.98% 1749.0% 454.47%
Total Short-Term Liabilities $1.431B $1.423B $1.490B
YoY Change -4.09% 46.15% 61.85%
LONG-TERM LIABILITIES
Long-Term Debt $2.700B $2.699B $2.691B
YoY Change 1.81% 1.14% 9.95%
Other Long-Term Liabilities $64.70M $67.10M $57.00M
YoY Change 32.58% 37.78% -31.9%
Total Long-Term Liabilities $64.70M $67.10M $57.00M
YoY Change 32.58% 37.78% -31.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.431B $1.423B $1.490B
Total Long-Term Liabilities $64.70M $67.10M $57.00M
Total Liabilities $4.864B $4.798B $4.832B
YoY Change 1.44% 13.56% 20.1%
SHAREHOLDERS EQUITY
Retained Earnings $4.762B $4.630B $4.489B
YoY Change 12.62% 11.94% 8.29%
Common Stock $2.491B $2.465B $2.433B
YoY Change 5.14% 4.55% 4.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.179B $4.133B $4.088B
YoY Change 8.56% 10.15% 11.12%
Treasury Stock Shares $381.2M $381.3M $381.5M
Shareholders Equity $2.698B $2.421B $2.176B
YoY Change
Total Liabilities & Shareholders Equity $7.562B $7.220B $7.008B
YoY Change 7.18% 14.8% 12.41%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income $176.2M $185.8M $179.0M
YoY Change 33.28% 464.74% 19.02%
Depreciation, Depletion And Amortization $93.20M $49.40M $45.90M
YoY Change 8.88% 7.86% 0.44%
Cash From Operating Activities $249.0M $207.1M $249.5M
YoY Change 41.4% -3.04% 24.56%
INVESTING ACTIVITIES
Capital Expenditures -$72.40M $64.80M $56.70M
YoY Change 13.13% 6.75% 20.9%
Acquisitions $151.9M $0.00
YoY Change 275.99%
Other Investing Activities -$158.7M -$5.700M $1.500M
YoY Change -73.07% -812.5% 66.67%
Cash From Investing Activities -$231.1M -$219.0M -$58.20M
YoY Change -64.63% 105.83% 21.76%
FINANCING ACTIVITIES
Cash Dividend Paid $43.90M $43.90M $44.00M
YoY Change 7.6% 7.6% 7.32%
Common Stock Issuance & Retirement, Net $50.00M $75.00M
YoY Change -33.33% 50.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.30M -$76.50M -$87.00M
YoY Change -107.61% -248.83% -51.61%
NET CHANGE
Cash From Operating Activities 249.0M $207.1M $249.5M
Cash From Investing Activities -231.1M -$219.0M -$58.20M
Cash From Financing Activities -26.30M -$76.50M -$87.00M
Net Change In Cash -8.400M -$87.60M $105.0M
YoY Change -93.62% -155.27% -500.76%
FREE CASH FLOW
Cash From Operating Activities $249.0M $207.1M $249.5M
Capital Expenditures -$72.40M $64.80M $56.70M
Free Cash Flow $321.4M $142.3M $192.8M
YoY Change 33.86% -6.93% 25.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
380841474
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3882467
CY2018 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
35637
CY2018 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
44602
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2178151
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
40578
CY2019 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
45226
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2155084
CY2020 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
27890
CY2020 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
44944
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11100000 USD
CY2019 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
10400000 USD
CY2018 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
3100000 USD
CY2020 vrsk Unbilled Receivables Expected Billing Period
UnbilledReceivablesExpectedBillingPeriod
P1Y
CY2020 vrsk Operating And Financing Lease Extension Lease Term
OperatingAndFinancingLeaseExtensionLeaseTerm
P20Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000.0 USD
CY2020Q4 vrsk Number Of Banks
NumberOfBanks
11 pure
CY2019Q4 vrsk Number Of Banks
NumberOfBanks
10 pure
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019 vrsk Revenue Remaining Performance Obligation Current Percentage
RevenueRemainingPerformanceObligationCurrentPercentage
0.99 pure
CY2020 vrsk Lessee Lease Option To Extend
LesseeLeaseOptionToExtend
P20Y
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
162791583
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
544003038
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
544003038
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162817526
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
163161564
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
381185512
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
200000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2020 vrsk Number Of Service Hours
NumberOfServiceHours
1000 pure
CY2019 vrsk Profit Sharing Contributions
ProfitSharingContributions
0 USD
CY2018 vrsk Profit Sharing Contributions
ProfitSharingContributions
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
936843
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.87
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
942049
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
18.30
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
134140
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
22.40
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2117613
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
23.39
CY2019 us-gaap Defined Benefit Plan Prescription Drug Benefit Accumulated Postretirement Benefit Obligation Decrease For Subsidy
DefinedBenefitPlanPrescriptionDrugBenefitAccumulatedPostretirementBenefitObligationDecreaseForSubsidy
800000 USD
CY2019 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 USD
CY2019 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
CY2018 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218800000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
184600000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
432400000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
441600000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
81200000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
60900000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
25400000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
25900000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36400000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17800000 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
14100000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
794200000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
744900000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
632300000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548100000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
267600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
218600000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1384800000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1398900000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4108100000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3864300000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9100000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9800000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
365700000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
159800000 USD
CY2020Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 USD
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
110800000 USD
CY2020Q4 us-gaap Assets
Assets
7561800000 USD
CY2019Q4 us-gaap Assets
Assets
7055200000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7561800000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
406700000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
375000000.0 USD
CY2020Q4 vrsk Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
600000 USD
CY2019Q4 vrsk Acquisition Related Liabilities Current
AcquisitionRelatedLiabilitiesCurrent
111200000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
514300000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
499400000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
466700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
440100000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38700000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40600000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3800000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6800000 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
18700000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1430800000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1491800000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2699600000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2651600000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
396900000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
356000000.0 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
271600000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
208100000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64700000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48800000 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
38100000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
4863600000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
4794400000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2490900000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2369100000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4179300000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3849900000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4762200000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4228400000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-375700000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-486900000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2698200000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2260800000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7055200000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2784600000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607100000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2395100000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
993900000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
976800000 USD
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
886200000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
413900000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
603500000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
378700000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
192200000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
185700000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165300000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165900000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
138000000.0 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130800000 USD
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
19400000 USD
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-6200000 USD
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-0 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1746500000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
1910200000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
1561000000.0 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
1038100000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
696900000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
834100000 USD
CY2020 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
-2400000 USD
CY2019 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
-1700000 USD
CY2018 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
15300000 USD
CY2020 us-gaap Interest Expense
InterestExpense
138200000 USD
CY2019 us-gaap Interest Expense
InterestExpense
126800000 USD
CY2018 us-gaap Interest Expense
InterestExpense
129700000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-140600000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-128500000 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-114400000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
897500000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
568400000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
719700000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184800000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
118500000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121000000.0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
712700000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
449900000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
598700000 USD
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.38
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.75
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.63
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.31
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162610586
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163535438
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164808110
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165320709
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166560115
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168297836
CY2020 us-gaap Net Income Loss
NetIncomeLoss
712700000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
449900000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
598700000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
107900000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
88400000 USD
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-154100000 USD
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-3300000 USD
CY2019 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-16600000 USD
CY2018 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
24800000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
111200000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
105000000.0 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-178900000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
823900000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
554900000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
419800000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1925400000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
598700000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-178900000 USD
CY2018 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
438600000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90800000 USD
CY2018 vrsk Restricted Stock Lapses
RestrictedStockLapses
0 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38500000 USD
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3700000 USD
CY2018 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3200000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2070600000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
449900000 USD
CY2019 us-gaap Dividends Common Stock
DividendsCommonStock
164100000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
105000000.0 USD
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
300000000.0 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57900000 USD
CY2019 vrsk Restricted Stock Lapses
RestrictedStockLapses
0 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42700000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5500000 USD
CY2019 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4300000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2260800000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
712700000 USD
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
176500000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
111200000 USD
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
348800000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
92200000 USD
CY2020 vrsk Restricted Stock Lapses
RestrictedStockLapses
0 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47600000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4100000 USD
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
5500000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2698200000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
712700000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
449900000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
598700000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
192200000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
185700000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165300000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165900000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
138000000.0 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130800000 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1800000 USD
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3900000 USD
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4200000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13100000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7200000 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5600000 USD
CY2020 vrsk Realized Gain On Subordinated Promissory Note
RealizedGainOnSubordinatedPromissoryNote
-0 USD
CY2019 vrsk Realized Gain On Subordinated Promissory Note
RealizedGainOnSubordinatedPromissoryNote
-0 USD
CY2018 vrsk Realized Gain On Subordinated Promissory Note
RealizedGainOnSubordinatedPromissoryNote
12300000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
19400000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6200000 USD
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-0 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
47600000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
42700000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
38500000 USD
CY2020 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-0 USD
CY2019 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
900000 USD
CY2018 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-100000 USD
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
31100000 USD
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-29300000 USD
CY2018 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
18300000 USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-600000 USD
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-300000 USD
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-300000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1800000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
70300000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17400000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66500000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19700000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
28200000 USD
CY2020 vrsk Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-43100000 USD
CY2019 vrsk Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-51300000 USD
CY2018 vrsk Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-0 USD
CY2020 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-500000 USD
CY2019 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
15000000.0 USD
CY2018 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-2900000 USD
CY2020 vrsk Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
-77000000.0 USD
CY2019 vrsk Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
70400000 USD
CY2018 vrsk Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
9700000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24300000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
150900000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
58100000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
21200000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11400000 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
800000 USD
CY2020 vrsk Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-29600000 USD
CY2019 vrsk Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-49500000 USD
CY2018 vrsk Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0 USD
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5800000 USD
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6900000 USD
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-35200000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1068200000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
956300000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
934400000 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
275800000 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
699200000 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138200000 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
23100000 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
94800000 USD
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
CY2020 vrsk Payments For Escrow Funding Associated With Acquisition
PaymentsForEscrowFundingAssociatedWithAcquisition
9300000 USD
CY2019 vrsk Payments For Escrow Funding Associated With Acquisition
PaymentsForEscrowFundingAssociatedWithAcquisition
4500000 USD
CY2018 vrsk Payments For Escrow Funding Associated With Acquisition
PaymentsForEscrowFundingAssociatedWithAcquisition
14900000 USD
CY2020 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0 USD
CY2019 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0 USD
CY2018 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
121400000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
246800000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
216800000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
231000000.0 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-7800000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7400000 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2700000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-595800000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-927900000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-265400000 USD
CY2020 vrsk Proceeds From Repayments Of Shortterm Debt Net Excluding Debt Maturing In More Than Three Months
ProceedsFromRepaymentsOfShorttermDebtNetExcludingDebtMaturingInMoreThanThreeMonths
-445000000.0 USD
CY2019 vrsk Proceeds From Repayments Of Shortterm Debt Net Excluding Debt Maturing In More Than Three Months
ProceedsFromRepaymentsOfShorttermDebtNetExcludingDebtMaturingInMoreThanThreeMonths
80000000.0 USD
CY2018 vrsk Proceeds From Repayments Of Shortterm Debt Net Excluding Debt Maturing In More Than Three Months
ProceedsFromRepaymentsOfShorttermDebtNetExcludingDebtMaturingInMoreThanThreeMonths
-300000000.0 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
250000000.0 USD
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 USD
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
494800000 USD
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
619700000 USD
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020 us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
20000000.0 USD
CY2019 us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
0 USD
CY2018 us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
0 USD
CY2020 us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
20000000.0 USD
CY2019 us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
-0 USD
CY2018 us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
-0 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5700000 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6300000 USD
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
348800000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
300000000.0 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
438600000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4100000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5500000 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3700000 USD
CY2020 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
34200000 USD
CY2019 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
-0 USD
CY2018 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
-0 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000000.0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
52400000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
87300000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
175800000 USD
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
163500000 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 USD
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14400000 USD
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-15900000 USD
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14800000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-445200000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10900000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-669800000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6700000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6100000 USD
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000000.0 USD
CY2020 vrsk Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCashHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
33900000 USD
CY2019 vrsk Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCashHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
45400000 USD
CY2018 vrsk Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsCashHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
-2800000 USD
CY2018 vrsk Cash Classified Within Current Assets Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashClassifiedWithinCurrentAssetsHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
0 USD
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
300000 USD
CY2020 vrsk Held For Sale Assets Contributed To Nonpublic Company
HeldForSaleAssetsContributedToNonpublicCompany
65900000 USD
CY2020 vrsk Operating Lease Obligations Incurred Net Of Terminations
OperatingLeaseObligationsIncurredNetOfTerminations
87800000 USD
CY2019 vrsk Operating Lease Obligations Incurred Net Of Terminations
OperatingLeaseObligationsIncurredNetOfTerminations
13700000 USD
CY2018 vrsk Operating Lease Obligations Incurred Net Of Terminations
OperatingLeaseObligationsIncurredNetOfTerminations
0 USD
CY2020 vrsk Tenant Improvements Included In Operating Lease Rightofuse Assets Net
TenantImprovementsIncludedInOperatingLeaseRightofuseAssetsNet
0 USD
CY2019 vrsk Tenant Improvements Included In Operating Lease Rightofuse Assets Net
TenantImprovementsIncludedInOperatingLeaseRightofuseAssetsNet
1700000 USD
CY2018 vrsk Tenant Improvements Included In Operating Lease Rightofuse Assets Net
TenantImprovementsIncludedInOperatingLeaseRightofuseAssetsNet
300000 USD
CY2020 vrsk Gain Loss On Disposition Of Property Plant Equipment Noncash
GainLossOnDispositionOfPropertyPlantEquipmentNoncash
3500000 USD
CY2019 vrsk Gain Loss On Disposition Of Property Plant Equipment Noncash
GainLossOnDispositionOfPropertyPlantEquipmentNoncash
0 USD
CY2020 vrsk Cash Classified Within Current Assets Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashClassifiedWithinCurrentAssetsHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
300000 USD
CY2019 vrsk Cash Classified Within Current Assets Held For Sale Period Increase Decrease Including Exchange Rate Effect
CashClassifiedWithinCurrentAssetsHeldForSalePeriodIncreaseDecreaseIncludingExchangeRateEffect
-300000 USD
CY2018 vrsk Gain Loss On Disposition Of Property Plant Equipment Noncash
GainLossOnDispositionOfPropertyPlantEquipmentNoncash
0 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
800000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1600000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34200000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45100000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2800000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184600000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139500000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142300000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218800000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184600000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139500000 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
156500000 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
139800000 USD
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
103200000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
134300000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
119900000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
125200000 USD
CY2020 vrsk Deferred Tax Liability Established On Date Of Acquisition
DeferredTaxLiabilityEstablishedOnDateOfAcquisition
13000000.0 USD
CY2019 vrsk Deferred Tax Liability Established On Date Of Acquisition
DeferredTaxLiabilityEstablishedOnDateOfAcquisition
43400000 USD
CY2018 vrsk Deferred Tax Liability Established On Date Of Acquisition
DeferredTaxLiabilityEstablishedOnDateOfAcquisition
5600000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
247600000 USD
CY2018 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
30900000 USD
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
20200000 USD
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
21300000 USD
CY2019 vrsk Held For Sale Assets Contributed To Nonpublic Company
HeldForSaleAssetsContributedToNonpublicCompany
0 USD
CY2018 vrsk Held For Sale Assets Contributed To Nonpublic Company
HeldForSaleAssetsContributedToNonpublicCompany
0 USD
CY2020 us-gaap Dividends
Dividends
700000 USD
CY2019 us-gaap Dividends
Dividends
600000 USD
CY2018 us-gaap Dividends
Dividends
0 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48900000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60000000.0 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45100000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
8500000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
10700000 USD
CY2018 us-gaap Advertising Expense
AdvertisingExpense
9000000.0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11700000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
432400000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
441600000 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
450100000 USD
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
453300000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17700000 USD
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000.0 USD
CY2020Q4 vrsk Cash Balances On Deposit Fdic Insured Amount
CashBalancesOnDepositFdicInsuredAmount
92800000 USD
CY2019Q4 vrsk Cash Balances On Deposit Fdic Insured Amount
CashBalancesOnDepositFdicInsuredAmount
36400000 USD
CY2020Q4 vrsk Cash Deposit With Foreign Banks
CashDepositWithForeignBanks
122500000 USD
CY2019Q4 vrsk Cash Deposit With Foreign Banks
CashDepositWithForeignBanks
145700000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2784600000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607100000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2395100000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2784600000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607100000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2395100000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
468200000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
443200000 USD
CY2020 vrsk Increase Decrease In Contract Liabilities
IncreaseDecreaseInContractLiabilities
25000000.0 USD
CY2020 vrsk Contract With Customer Liability Billings Paid In Advance
ContractWithCustomerLiabilityBillingsPaidInAdvance
418500000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
393500000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
468200000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
443200000 USD
CY2020 vrsk Revenue Remaining Performance Obligation Current Percentage
RevenueRemainingPerformanceObligationCurrentPercentage
0.99 pure
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
73800000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
63700000 USD
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
44900000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27100000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
24700000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
52200000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
48400000 USD
CY2020 us-gaap Sublease Income
SubleaseIncome
300000 USD
CY2019 us-gaap Sublease Income
SubleaseIncome
-0 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13400000 USD
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13200000 USD
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
700000 USD
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1800000 USD
CY2020 us-gaap Lease Cost
LeaseCost
66000000.0 USD
CY2019 us-gaap Lease Cost
LeaseCost
63400000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
52000000.0 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
48400000 USD
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
700000 USD
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1800000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
14400000 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15100000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039 pure
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040 pure
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.044 pure
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
9900000 USD
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7700000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
50500000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
15000000.0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
45000000.0 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
10800000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
42900000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
300000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
35200000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
31900000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
171400000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
376900000 USD
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
26100000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
66600000 USD
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1400000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
310300000 USD
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
24700000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1469300000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
837000000.0 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
632300000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1280000000.0 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
731900000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548100000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
192200000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
185700000 USD
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165300000 USD
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
120600000 USD
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
100200000 USD
CY2018 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
85400000 USD
CY2020Q4 vrsk Unamortized Costs Capitalized
UnamortizedCostsCapitalized
53500000 USD
CY2019Q4 vrsk Unamortized Costs Capitalized
UnamortizedCostsCapitalized
46700000 USD
CY2020 vrsk Escrow Release
EscrowRelease
800000 USD
CY2019 vrsk Escrow Release
EscrowRelease
25200000 USD
CY2020Q4 vrsk Current Portion Of Escrow
CurrentPortionOfEscrow
1700000 USD
CY2019Q4 vrsk Current Portion Of Escrow
CurrentPortionOfEscrow
500000 USD
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
18500000 USD
CY2019Q4 us-gaap Escrow Deposit
EscrowDeposit
10500000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
600000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
111200000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
200000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
156900000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
144300000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
139400000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
114700000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
659600000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1384800000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
834000000.0 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
553900000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
700200000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
63500000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
14500000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
19500000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
897500000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
568400000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
719700000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
111000000.0 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
109900000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
69000000.0 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
23100000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21400000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
22100000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
18900000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
14600000 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11100000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
153000000.0 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
145900000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
102200000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
22600000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-14300000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
27600000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7400000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-200000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2800000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1800000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-12900000 USD
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-11600000 USD
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206 pure
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209 pure
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.168 pure
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
31800000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-27400000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18800000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184800000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
118500000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121000000.0 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.027 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.028 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.028 pure
CY2020 vrsk Effective Income Tax Rate Reconciliation Change In Foreign Enacted Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInForeignEnactedTaxRatePercent
0.015 pure
CY2018 vrsk Effective Income Tax Rate Reconciliation Change In Foreign Enacted Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInForeignEnactedTaxRatePercent
0 pure
CY2017 vrsk Effective Income Tax Rate Reconciliation Change In Foreign Enacted Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInForeignEnactedTaxRatePercent
0 pure
CY2020 vrsk Effective Income Tax Rate Reconciliation Tax Expense Benefit Foreign Derived Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitForeignDerivedRateChangePercent
-0.008 pure
CY2018 vrsk Effective Income Tax Rate Reconciliation Tax Expense Benefit Foreign Derived Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitForeignDerivedRateChangePercent
-0.012 pure
CY2017 vrsk Effective Income Tax Rate Reconciliation Tax Expense Benefit Foreign Derived Rate Change Percent
EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitForeignDerivedRateChangePercent
-0.009 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.037 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.030 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.055 pure
CY2020 vrsk Effective Income Tax Rate Reconciliation Earnouts Percent
EffectiveIncomeTaxRateReconciliationEarnoutsPercent
0 pure
CY2018 vrsk Effective Income Tax Rate Reconciliation Earnouts Percent
EffectiveIncomeTaxRateReconciliationEarnoutsPercent
0.020 pure
CY2017 vrsk Effective Income Tax Rate Reconciliation Earnouts Percent
EffectiveIncomeTaxRateReconciliationEarnoutsPercent
0.001 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007 pure
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
7300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
13000000.0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
10300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
7300000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22700000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28800000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
31300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
31200000 USD
CY2020Q4 vrsk Deferred Tax Assets Capital And Other Unrealized Loss Carryforwards
DeferredTaxAssetsCapitalAndOtherUnrealizedLossCarryforwards
1600000 USD
CY2019Q4 vrsk Deferred Tax Assets Capital And Other Unrealized Loss Carryforwards
DeferredTaxAssetsCapitalAndOtherUnrealizedLossCarryforwards
1700000 USD
CY2020Q4 vrsk Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
44100000 USD
CY2019Q4 vrsk Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
33400000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
12200000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
16400000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
129500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
131800000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48000000.0 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46500000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
81500000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
85300000 USD
CY2020Q4 vrsk Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
445300000 USD
CY2019Q4 vrsk Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
411000000.0 USD
CY2020Q4 vrsk Deferred Tax Liabilities Commissions
DeferredTaxLiabilitiesCommissions
16600000 USD
CY2019Q4 vrsk Deferred Tax Liabilities Commissions
DeferredTaxLiabilitiesCommissions
14300000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7400000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6200000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
469300000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
431500000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
387800000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
346200000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
387800000 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
221100000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11500000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17400000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16300000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
500000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
600000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2000000.0 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
200000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
3300000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
100000 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
-0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
2400000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
300000 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1900000 USD
CY2018Q4 vrsk Common Stock Weighted Average Price
CommonStockWeightedAveragePrice
8.71
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
800000 USD
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
500000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9900000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11500000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17400000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8100000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8600000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14400000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3900000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
4600000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
5700000 USD
CY2020Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
5800000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
158700000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
147400000 USD
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
126500000 USD
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
128400000 USD
CY2020Q4 vrsk Escrow Liabilities Current
EscrowLiabilitiesCurrent
1500000 USD
CY2019Q4 vrsk Escrow Liabilities Current
EscrowLiabilitiesCurrent
200000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20700000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
19000000.0 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
99300000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
80000000.0 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
406700000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
375000000.0 USD
CY2020Q4 vrsk Pension Benefit Assets Noncurrent
PensionBenefitAssetsNoncurrent
77300000 USD
CY2019Q4 vrsk Pension Benefit Assets Noncurrent
PensionBenefitAssetsNoncurrent
60300000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
70600000 USD
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
57000000.0 USD
CY2020Q4 vrsk Business Acquisition Escrow Noncurrent
BusinessAcquisitionEscrowNoncurrent
18500000 USD
CY2019Q4 vrsk Business Acquisition Escrow Noncurrent
BusinessAcquisitionEscrowNoncurrent
10500000 USD
CY2020Q4 vrsk Investments Noncurrent
InvestmentsNoncurrent
192600000 USD
CY2019Q4 vrsk Investments Noncurrent
InvestmentsNoncurrent
27100000 USD
CY2020Q4 vrsk Deposits And Other Noncurrent Assets
DepositsAndOtherNoncurrentAssets
6700000 USD
CY2019Q4 vrsk Deposits And Other Noncurrent Assets
DepositsAndOtherNoncurrentAssets
4900000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
365700000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
159800000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
14400000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4400000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
514300000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
499400000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10300000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3300000 USD
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1600000 USD
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2100000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2699600000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2651600000 USD
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3213900000 USD
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3151000000.0 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20700000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
19000000.0 USD
CY2020 vrsk Interest Expense Excluding Earn Out Interest
InterestExpenseExcludingEarnOutInterest
138300000 USD
CY2019 vrsk Interest Expense Excluding Earn Out Interest
InterestExpenseExcludingEarnOutInterest
125700000 USD
CY2018 vrsk Interest Expense Excluding Earn Out Interest
InterestExpenseExcludingEarnOutInterest
128200000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3150000000.0 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2650000000.0 USD
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
5400000 USD
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4800000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
514400000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
360000000.0 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
300000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
900000000.0 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1450000000.0 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
3224700000 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000
CY2020Q4 us-gaap Share Price
SharePrice
207.59
CY2019Q4 us-gaap Share Price
SharePrice
149.34
CY2018Q4 us-gaap Share Price
SharePrice
108.28
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
43900000 USD
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
44000000.0 USD
CY2020Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
43900000 USD
CY2020Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
43900000 USD
CY2020 vrsk Accelerated Share Repurchases Initial Price Shares
AcceleratedShareRepurchasesInitialPriceShares
1339462
CY2020 vrsk Common Stock Reissued
CommonStockReissued
1811046
CY2019 vrsk Common Stock Reissued
CommonStockReissued
1369305
CY2018 vrsk Common Stock Reissued
CommonStockReissued
2973947
CY2020Q4 vrsk Common Stock Weighted Average Price
CommonStockWeightedAveragePrice
10.67
CY2019Q4 vrsk Common Stock Weighted Average Price
CommonStockWeightedAveragePrice
9.72
CY2020 us-gaap Net Income Loss
NetIncomeLoss
712700000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
449900000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
598700000 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162610586
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163535438
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164808110
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2710123
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3024677
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3489726
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165320709
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166560115
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
3361500000 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
453500000 USD
CY2019 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
8600000 USD
CY2019 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1500000 USD
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
59400000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3864300000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
171700000 USD
CY2020 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-4100000 USD
CY2020 vrsk Goodwill Reclassification Adjustments
GoodwillReclassificationAdjustments
1900000 USD
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
74300000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4108100000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2345100000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
960300000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1384800000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2175300000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
776400000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1398900000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165900000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
138000000.0 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130800000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
169900000 USD
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168297836
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
513137
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
674983
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
496446
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-292200000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-400100000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
83500000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
86800000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-375700000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-486900000 USD
CY2020 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
112300000 USD
CY2020 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1100000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
111200000 USD
CY2019 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
110200000 USD
CY2019 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
5200000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
105000000.0 USD
CY2018 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-187100000 USD
CY2018 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-8200000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-178900000 USD
CY2020 vrsk Profit Sharing Contributions
ProfitSharingContributions
0 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8907109
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.31
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
380200000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
958332
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
104.23
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2752735
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
33.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
213000000.0 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
292660
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
79.16
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6820046
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.27
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
284900000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
920398
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
135.64
CY2019 vrsk Sharebased Compensation Arrangement By Sharebased Payment Award Options Dividends Reinvested In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsDividendsReinvestedInPeriod
0
CY2019 vrsk Sharebased Compensation Arrangements By Sharebased Payment Award Options Dividends Reinvested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsDividendsReinvestedInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1131970
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
51.20
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
101000000.0 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
175660
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
92.27
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6432814
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
79.51
CY2019 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
-1700000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
449200000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
936843
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
159.28
CY2020 vrsk Sharebased Compensation Arrangement By Sharebased Payment Award Options Dividends Reinvested In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsDividendsReinvestedInPeriod
0
CY2020 vrsk Sharebased Compensation Arrangements By Sharebased Payment Award Options Dividends Reinvested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsDividendsReinvestedInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1623740
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
56.83
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
189800000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
134140
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
125.95
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5611777
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
98.28
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
613400000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3494164
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.84
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
456900000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4175855
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
65.05
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
352000000.0 USD
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2117613
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1900586
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.1848 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.1876 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.1851 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0151 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0225 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0253 pure
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y4M24D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0071 pure
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0080 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.87
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.13
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.48
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2911770
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
14.86
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
958332
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.48
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1117513
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
14.79
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
292660
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
15.33
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2459929
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
17.41
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
920398
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.13
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
947708
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
17.29
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
175660
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
17.77
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2256959
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
20.17
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
42900000 USD
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
23200000 USD
CY2018 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
48900000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47600000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42700000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38500000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
88000000.0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
52400000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
87300000 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
82400000 USD
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
20100000 USD
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
17400000 USD
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
16800000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.200 pure
CY2020 vrsk Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Short Term Incentive Compensation Available For Payroll Deductions Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfShortTermIncentiveCompensationAvailableForPayrollDeductionsMaximum
0.500 pure
CY2020Q4 vrsk Share Based Compensation Arrangement By Share Based Payment Award Payroll Deductions Amount Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPayrollDeductionsAmountMaximum
25000.0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
0.050 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
0.050 pure
CY2019 us-gaap Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1
PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
48500 USD
CY2018 us-gaap Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1
PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
51000.0 USD
CY2020 vrsk Changes In Assumed Healthcare Cost Trend Rate
ChangesInAssumedHealthcareCostTrendRate
1.00 pure
CY2020 us-gaap Defined Benefit Plan Prescription Drug Benefit Accumulated Postretirement Benefit Obligation Decrease For Subsidy
DefinedBenefitPlanPrescriptionDrugBenefitAccumulatedPostretirementBenefitObligationDecreaseForSubsidy
800000 USD
CY2020 us-gaap Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1
PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
58200 USD
CY2020Q4 us-gaap Defined Benefit Plan Plan Assets Target Allocation Percentage
DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
1.000 pure
CY2020Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1.000 pure
CY2019Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1.000 pure
CY2020Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
531300000 USD
CY2019Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
499200000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2784600000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2607100000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2395100000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
993900000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
976800000 USD
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
886200000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
413900000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
603500000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
378700000 USD
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
19400000 USD
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-6200000 USD
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2020 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
-2400000 USD
CY2018 vrsk Investment Loss Income And Other Net
InvestmentLossIncomeAndOtherNet
15300000 USD
CY2020 vrsk Earnings Before Interest Income Taxes Depreciation And Amortization From Reportable Segment
EarningsBeforeInterestIncomeTaxesDepreciationAndAmortizationFromReportableSegment
1393800000 USD
CY2019 vrsk Earnings Before Interest Income Taxes Depreciation And Amortization From Reportable Segment
EarningsBeforeInterestIncomeTaxesDepreciationAndAmortizationFromReportableSegment
1018900000 USD
CY2018 vrsk Earnings Before Interest Income Taxes Depreciation And Amortization From Reportable Segment
EarningsBeforeInterestIncomeTaxesDepreciationAndAmortizationFromReportableSegment
1145500000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
192200000 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
185700000 USD
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165300000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165900000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
138000000.0 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
130800000 USD
CY2020 us-gaap Interest Expense
InterestExpense
138200000 USD
CY2019 us-gaap Interest Expense
InterestExpense
126800000 USD
CY2018 us-gaap Interest Expense
InterestExpense
129700000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
897500000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
568400000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
719700000 USD
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
6767600000 USD
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
6310300000 USD
CY2020 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 USD
CY2020Q4 vrsk Percentage Of Ownership On Outstanding Common Stock Required To Become Related Party
PercentageOfOwnershipOnOutstandingCommonStockRequiredToBecomeRelatedParty
0.05 pure
CY2020 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD

Files In Submission

Name View Source Status
0001437749-21-003789-index-headers.html Edgar Link pending
0001437749-21-003789-index.html Edgar Link pending
0001437749-21-003789.txt Edgar Link pending
0001437749-21-003789-xbrl.zip Edgar Link pending
ex_216469.htm Edgar Link pending
ex_216470.htm Edgar Link pending
ex_216471.htm Edgar Link pending
ex_216472.htm Edgar Link pending
ex_227497.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
priorpeergroupchart.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrsk-20201231.xsd Edgar Link pending
vrsk-20201231_cal.xml Edgar Link unprocessable
vrsk-20201231_def.xml Edgar Link unprocessable
vrsk-20201231_lab.xml Edgar Link unprocessable
vrsk-20201231_pre.xml Edgar Link unprocessable
vrsk20201120_10k.htm Edgar Link pending
vrsk20201120_10k_htm.xml Edgar Link completed